Vivian Kosmidou

Vas. Constantinou Ave. 48
Athens, ESYE31 11635, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

2-Cyclopropanecarboxamido- 6-carboxamide substituted benzothiazoles: Synthesis, in vitro and in vivo evaluation of their antiproliferative and anti-tumorigenic activity.

2-Cyclopropanecarboxamido- 6-carboxamide substituted benzothiazoles: Synthesis, in vitro and in vivo evaluation of their antiproliferative and anti-tumorigenic activity.

Journal: Bioorganic & medicinal chemistry

Published: July 26, 2025

Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer.

Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer.

Journal: Molecular oncology

Published: June 26, 2024

Design and Synthesis of Novel 2-Acetamido, 6-Carboxamide Substituted Benzothiazoles as Potential BRAFV600E Inhibitors - In vitro Evaluation of their Antiproliferative Activity.

Design and Synthesis of Novel 2-Acetamido, 6-Carboxamide Substituted Benzothiazoles as Potential BRAFV600E Inhibitors - In vitro Evaluation of their Antiproliferative Activity.

Journal: ChemMedChem

Published: June 23, 2023

BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis.

BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: August 17, 2020

Noxa upregulation and 5-gene apoptotic biomarker panel in colorectal cancer.

Noxa upregulation and 5-gene apoptotic biomarker panel in colorectal cancer.

Journal: European journal of clinical investigation

Published: April 19, 2020

Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer.

Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer.

Journal: Scientific reports

Published: February 18, 2016

Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network (miR-21-ITGΒ4-PDCD4) as predictor of metastatic tumor potential.

Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network (miR-21-ITGΒ4-PDCD4) as predictor of metastatic tumor potential.

Journal: Epigenetics

Published: October 24, 2013

Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications.

Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications.

Journal: Human mutation

Published: May 30, 2013

EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells.

EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells.

Journal: The international journal of biochemistry & cell biology

Published: July 04, 2012

A molecular signature for oncogenic BRAF in human colon cancer cells is revealed by microarray analysis.

A molecular signature for oncogenic BRAF in human colon cancer cells is revealed by microarray analysis.

Journal: Current cancer drug targets

Published: October 19, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026